Inhibition of the Wnt/β-catenin signaling pathway by anti-miR-181 inhibitors suppressed stemness gene expression and tumorigenicity of EpCAM+ HCC [99]. This evidence concerns the gene EPCAM and hepatocellular carcinoma.